2023 annual financial data
Ionis Pharmaceuticals 2023 Operating margin
Ionis Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was -44.91%.
Operating income was -353,730,000 USD and net income was -366,286,000 USD.
Operating cash flow was -307,513,000 USD.
Get free Ionis Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 787,647,000 USD
- Operating income
- -353,730,000 USD
- Net income
- -366,286,000 USD
- Operating cash flow
- -307,513,000 USD